Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hansch

Showing results (11-20 of 383) with videos related to

Pageof 39
Sort By:
Therapeutische Umschau. Revue Therapeutique|October 3, 2019
[Anxiety and psychosomatic Desease. Escalation mechanisms and therapeutic strategies from the perspective of systems theory and behavioral therapy]Dietmar Hansch
Drug Metabolism Reviews|January 1, 1984
The QSAR paradigm in the design of less toxic moleculesC Hansch
Zeitschrift Fur Psychologie Mit Zeitschrift Fur Angewandte Psychologie|January 1, 1988
[Psychosynergetics--new perspectives for neuropsychology? Principles of the psychosynergetic theory of emotional and motivational processes]D Hansch
Progress in Clinical and Biological Research|January 1, 1989
Comparative structure-activity relationshipsC Hansch
Journal of Medicinal Chemistry|September 1, 1970
The use of sigma in structure-activity correlationsC Hansch
Drug Intelligence & Clinical Pharmacy|May 1, 1982
Dihydrofolate reductase inhibition. A study in the use of X-ray crystallography, molecular graphics, and quantitative structure-activity relations in drug designC Hansch
Cancer Chemotherapy Reports. Part 3|May 1, 1972
Structure-activity relationships: strategy in drug designC Hansch
Il Farmaco; Edizione Scientifica|January 1, 1979
QSAR in cancer chemotherapyC Hansch
Physical Review. A, General Physics|November 1, 1986
Absolute calibration of the 130Te2 reference line for positronium 1 3S1-2 3S1 spectroscopyMcIntyre, Hansch
The Journal of Organic Chemistry|March 1, 1970
Steric parameters in structure-activity correlations. Cholinesterase inhibitorsC Hansch
Pageof 39

Showing results (11-20 of 383) with videos related to

Sort By:
Pageof 39
Therapeutische Umschau. Revue Therapeutique|October 3, 2019
[Anxiety and psychosomatic Desease. Escalation mechanisms and therapeutic strategies from the perspective of systems theory and behavioral therapy]Dietmar Hansch
Drug Metabolism Reviews|January 1, 1984
The QSAR paradigm in the design of less toxic moleculesC Hansch
Zeitschrift Fur Psychologie Mit Zeitschrift Fur Angewandte Psychologie|January 1, 1988
[Psychosynergetics--new perspectives for neuropsychology? Principles of the psychosynergetic theory of emotional and motivational processes]D Hansch
Progress in Clinical and Biological Research|January 1, 1989
Comparative structure-activity relationshipsC Hansch
Journal of Medicinal Chemistry|September 1, 1970
The use of sigma in structure-activity correlationsC Hansch
Drug Intelligence & Clinical Pharmacy|May 1, 1982
Dihydrofolate reductase inhibition. A study in the use of X-ray crystallography, molecular graphics, and quantitative structure-activity relations in drug designC Hansch
Cancer Chemotherapy Reports. Part 3|May 1, 1972
Structure-activity relationships: strategy in drug designC Hansch
Il Farmaco; Edizione Scientifica|January 1, 1979
QSAR in cancer chemotherapyC Hansch
Physical Review. A, General Physics|November 1, 1986
Absolute calibration of the 130Te2 reference line for positronium 1 3S1-2 3S1 spectroscopyMcIntyre, Hansch
The Journal of Organic Chemistry|March 1, 1970
Steric parameters in structure-activity correlations. Cholinesterase inhibitorsC Hansch
Pageof 39